Research Article, Androl Gynecol Curr Res Vol: 1 Issue: 4
The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma
Joseph Menczer* |
E.Wolfson Med CTR, Holon, Israel |
Corresponding author : Joseph Menczer, MD E. Wolfson Med CTR, Holon, Israel Tel: 792 52 3511971; Fax: 792 3 5028812, E-mail: joseph12@internet-zahav.net |
Received: May 10, 2013 Accepted: September 10, 2013 Published: September 18, 2013 |
Citation: Menczer J (2013) The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma. Androl Gynecol: Curr Res 1:4. doi:10.4172/2327-4360.1000108 |
Abstract
The Significance of Normal Pretreatment Levels of Ca125 (<35 U/Ml) in Epithelial Ovarian Carcinoma
Investigations dealing specifically with the prognostic significance of normal (<35 U/mL) pretreatment serum levels in epithelial ovarian cancer (EOC) patients are scarce. The purpose of the present investigation was to assess the association between normal CA125 levels at diagnosis of EOC with prognostic factors and with outcome.